1-2 of 2
Alexander Aledo, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Philadelphia Chromosome Negative (Ph-) Very High Risk (VHR) Acute Lymphoblastic Leukemia (ALL) in Children and Adolescents: The Impact of Intensified Chemotherapy on Early Event Free Survival (EFS) in Children’s Oncology Group (COG) Study AALL0031.

Kirk R. Schultz, MD, William Paul Bowman, William Slayton, MD, Alexander Aledo, MD, Meenakshi Devidas, PhD, Harland Sather, PhD, Michael J. Borowitz, MD, PhD, Stella M. Davies, MBBS, PhD, Michael Trigg, MD, Bernice Pasut, RN, Dean Jorstad, RPh, Tammie Eslinger, CCRP, Laura Burden, CCRP, Chenguang Wang, MS, Robert Rutledge, MD, Bruce Camitta, MD, Paul S. Gaynon, MD, Andrew J. Carroll, PhD, Nyla A. Heerema, PhD, Naomi Winick, MD, Stephen P. Hunger, MD, William L. Carroll, MD
Journal: Blood
Blood (2008) 112 (11): 911.
https://doi.org/10.1182/blood.V112.11.911.911
Published: 2008
Journal Articles

Minimal Toxicity of Imatinib Mesylate in Combination with Intensive Chemotherapy for Philadelphia Chromosome Positive (Ph+) Acute Lymphoblastic Leukemia (ALL) in Children: A Report of the Children’s Oncology Group (COG) AALL0031 Protocol for Very High Risk ALL.

Kirk R. Schultz, MD, Alexander Aledo, MD, W. Paul Bowman, MD, William Slayton, MD, PhD, Harland Sather, PhD, Cheryl L. Willman, PhD, Julie M. Gastier-Foster, PhD, Nyla A. Heerema, PhD, Andrew J. Carroll, PhD, Michael J. Borowitz, PhD, Naomi Winick, MD, Stephen P. Hunger, MD, PhD, William L. Carroll, MD, PhD
Journal: Blood
Blood (2006) 108 (11): 283.
https://doi.org/10.1182/blood.V108.11.283.283
Published: 2006